Allegrow Biotech
Allegrow Biotech started in March 2022, as a spinoff start-up from the biomaterials laboratory at the Hong Kong University of Science & Technology.
Our vision is to bring quality and cost-effective cell therapeutic products to the patients. We have a mission to bring together engineers and scientists to innovate and deliver solutions for immune cell engineering to meet the needs of both research and clinical applications.
Our Journey so far
November 17, 2023Read more...We are exhilarated to share that Allegrow has emerged triumphant as the Winner at Jumpstarter...Read more...Wonderful news! Allegrow was awarded with Gold Medal in 2023 48th Geneva International Exhibition...April 11, 2023Read more...We are thrilled to announce that Allegrow is one of the Technology Start-up Support Scheme for...
Powered By
